References
- 1. Kunz C, Kuntz S, RudloffS. Intestinal flora. Adv Exp Med Biol 2009; 639:67-79.
- 2. Morelli L. Postnatal development of intestinal microflora as influenced by infant nutrition. J Nutr 2008; 138(9):1791S-5S.
- 3. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136(1):65-80.
- 4. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124(4):837-48.
- 5. Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract 2012; 2012:872716.
- 6. Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol 2013; 9(9):560-9.
- 7. Firoozeh F. Gut microbiome and human health. Int J Enteric Pathog 2019; 7(2):30.
- 8. Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 2008; 76(8):3360-73.
- 9. Di Mauro A, Neu J, Riezzo G et al. Gastrointestinal function development and microbiota. Ital J Pediatr 2013;39:15.
- 10. Dudek-Wicher RK, Junka A, Bartoszewicz M. The influence of antibiotics and dietary components on gut microbiota. Prz Gastroenterol 2018; 13(2):85-92.
- 11. Sánchez B, Delgado S, Blanco-Míguez A et al. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr & Food Res 2017; 61(1):1-15.
- 12. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 2017;9(9):1-30.
- 13. Allen SJ, Okoko B, Martinez E et al. Probiotics for treating infectious diarrhoea. Cochrane Database of Syst Rev 2004; 2: CD003048
- 14. Logan AC, Jacka FN. Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J Physiol Anthropol 2014; 33:22.
- 15. Daniluk U. Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment? J Clin Exp Oncol 2012; 1:2.
- 16. Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health 2014; 11(5):4745-67.
- 17. George Kerry R, Patra JK, Gouda S et al. Benefaction of probiotics for human health: A review. J Food Drug Anal 2018;26(3):927-39.
- 18. Figueroa-González I, Quijano G, Ramírez G et al. Probiotics and prebiotics--perspectives and challenges. J Sci Food Agric 2011;91(8):1341-8.
- 19. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111:1-66.
- 20. Cencic A, Chingwaru W. The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients 2010; 2(6):611-25.
- 21. Peña AS. [Intestinal flora, probiotics, prebiotics, symbiotics and novel foods]. Rev Esp Enferm Dig 2007; 99(11):653-8.
- 22. Romeo J, Nova E, Wärnberg J et al. Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr Hosp 2010; 25(3):341-9.
- 23. Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 2015; 52(12):7577-87.
- 24. Zhang MM, Cheng JQ, Lu YR et al. Use of pre-, pro-and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol 2010; 16(31):3970-8.
- 25. Saad N, Delattre C, Urdaci M et al. An overview of the last advances in probiotic and prebiotic field. Lebensm Wiss Techno 2013; 50(1), 1-16.
- 26. Corrêa NB, Péret Filho LA, Penna FJ et al. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005; 39(5):385-9.
- 27. Mahmoudi R, Fakhri O, Farhoodi A et al. A Review on probiotic dairy products as functional foods reported from Iran. Int J Food Nutr Saf 2015; 6(1): 1-12.
- 28. Guerra PV, Lima LN, Souza TC et al. Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J Gastroenterol 2011; 17(34):3916-21.
- 29. Goldenberg JZ, Ma SS, Saxton JD et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013;(5):CD006095.
- 30. Szajewska H, Canani RB, Guarino A et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 2016;62(3):495-506.
- 31. Pattani R, Palda VA, Hwang SW et al. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med 2013;7(2):e56-67.
- 32. Parvez S, Malik KA, Ah Kang S et al. Probiotics and their fermented food products are beneficial for health. J Appl Micro-biol 2006; 100(6), 1171-85.
- 33. Kim JY, Woo HJ, Kim YS et al. Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp lactis in SNUC2A, a colon cancer cell line. Nutr Cancer 2003; 46(2): 197-201.
- 34. Ghoneum M, Wang L, Agrawal S et al. Yeast therapy for the treatment of breast cancer: anude mice model study. In Vivo 2007; 21(2):251-8.
- 35. Mobarez AM., Doust RH, Hassan ZM et al. Antimutagenic effect of Lactobacillus acidophilus and Lactobacillus bulgaricus isolated from Iranian yoghurt on 2-nitrofluorene. Res J Micro-biol 2007;2(6):524-9.
- 36. Koller VJ, Marian B, Stidl R et al. Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells. Food Chem Toxicol 2008; 46(4): 1221-9.
- 37. Boniadi F, Tukmechi A, Nejati V. Comparative study on the effect of obtained cell wall and cytoplasmic fraction from Saccharomyces cerevisiae and Saccharomyces boulardii on K562cell line. Pharm Sci 2012; 18(1):69-78.
- 38. An J, Ha EM. Combination therapy of Lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells. J Microbiol Biotechnol 2016; 26(8):1490-503.
- 39. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74(10):720-6.
- 40. Soltani Z, Jafari P, Azadegan Ghomi HR. The effect of lacto-bacillus casei TD2, native Iranian probiotic, on corticosterone hormone secretion in male Wistar rats under chronic restraint stress condition. J Biol Sci 2014;7(1):65-72.
- 41. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87(3):873-904.
- 42. Paterson LM, Nutt DJ, Wilson SJ. NAPSAQ-1: national patient sleep assessment questionnaire in depression. Int J Psychiatry Clin Pract 2009; 13(1):48-58.
- 43. Jackson ML, Butt H, Ball M et al. Sleep quality and the treatment of intestinal microbiota imbalance in chronic fatigue syndrome: a pilot study. Sleep Sci 2015; 8(3):124-33.
- 44. Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry 2017;16:14.
- 45. Kawai T, Takeuchi O, Fujita T et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. The J Immunol 2001; 167(10):5887-94.
- 46. Carroll IM, Ringel-Kulka T, Keku TO et al. Molecular analysis of the luminal- and mucosal-associated intestinal micro-biota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301(5):G799-807.
- 47. Savcheniuk O, Kobyliak N, Kondro M et al. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with gluta-mate-induced obesity. BMC Complement Altern Med 2014; 14:247.
- 48. Ritze Y, Bárdos G, Claus A et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One 2014; 9(1):e80169.
- 49. Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008; 49(5):821-30.
- 50. Seo M, Inoue I, Tanaka M et al. Clostridium butyricum MIYAIRI 588 improves high-fat diet induced non-alcoholic fatty liver disease in rats. Dig Dis Sci 2013; 58(12):3534-44.
- 51. Endo H, Niioka M, Kobayashi N et al. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One 2013; 8(5):e63388.
- 52. Sepideh A, Karim P, Hossein A et al. Effects of multistrain probiotic supplementation on glycemic and inflammatory indices in patients with nonalcoholic fatty liver disease: a double- blind randomized clinical trial. J Am Coll Nutr 2016;35(6):500-5.
- 53. Zhang M, Wang C, Wang C et al. Enhanced AMPK phosphor-ylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease. J Nutr Biochem 2015; 26: 337-44.
- 54. Liang S, Webb T, Li Z. Probiotic antigens stimulate hepatic natural killer T cells. Immunology 2014; 141(2): 203-10.
- 55. Villena J, Kitazawa H. Probiotic microorganisms: a closer look. Microorganisms 2017; 5(2). pii: E17.
- 56. Selle K, Klaenhammer TR. Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health. FEMS Microbiol Rev 2013; 37(6):915-35.
- 57. Elshaghabee FMF, Rokana N, Gulhane RD et al. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol 2017; 8:1490.
- 58. Ianiro G, Rizzatti G, Plomer M et al. Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials. Nutrients 2018; 10(8). pii: E1074.
- 59. Salas-Jara MJ, Ilabaca A, Vega M et al. Biofilm forming Lactobacillus: new challenges for the development of probiotics. Microorganisms 2016; 4(3). pii: E35.